Macaso, Mario .
HRN: 23-06-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/19/2023
05/26/2023
IV
2.25gms
Q8
T/C Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes